DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...
ProVerum has closed an $80m Series B equity financing round, boosting commercialisation efforts for its ProVee system for benign prostatic hyperplasia (BPH). The funding round was led by MVM Partners, ...
DUBLIN, March 20, 2024 /PRNewswire/ -- ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, ...
DUBLIN, Jan. 21, 2026 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced ...
La Cámara de Comercio de Bucaramanga reafirma su compromiso con la economía popular de la región al liderar la tercera edición de “Provee Showroom”, un encuentro empresarial dirigido a los sectores de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results